All News
Filter News
Found 806,258 articles
-
Researchers Working to Understand Why Some Patients with Autoimmune Diseases Develop Diabetes Ins...
11/21/2019
A peculiarity of autoimmune diseases is that they have many genes in common, but they develop differently. -
The company’s consumer health unit is worth about $30 billion.
-
BMS Completes $74 Billion Celgene Takeover
11/21/2019
With the acquisition complete, Celgene is now a wholly-owned subsidiary of BMS. The combined companies have nine products with more than $1 billion in annual sales. -
The new deal builds on a discovery agreement signed in October 2017.
-
PACT Pharma Appoints Uneek Mehra as Chief Financial Officer
11/21/2019
Mehra brings significant experience scaling organizations, an important skill as PACT grows and enters the clinic.
-
Medinas Opens Florida Office to Serve Hospitals and Imaging Centers In Remarketing Pre-Owned Medical Equipment
11/21/2019
Tech-driven asset management platform will be contracted with 40 hospitals in the region by year’s end, plans to add 60 more by fall 2020
-
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
11/21/2019
Global Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced that it plans to release unaudited financial results for the second quarter and first half of fiscal year 2020 on Tuesday, November 26, 2019, after the market close.
-
Cancer Stat Launched by Templeton Apus: Cancer Patients Worldwide Finally Have a News Service Designed for Their Needs
11/21/2019
After a few close friends were diagnosed with cancer, Templeton Apus was alerted to the fact that there was no in-depth service specifically designed to keep cancer patients on top of cancer updates and treatments worldwide. The launch of its Cancer Stat global news service has changed that.
-
ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa
11/21/2019
ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA medicines for severe genetic rare diseases, announced that it received Orphan Drug designation from the Food and Drug Administration for QR-1123.
-
Clarkston's Life Sciences Accelerator Launches to Allow for Rapid Deployment of SAP S/4HANA®
11/21/2019
Leading life sciences consulting firm Clarkston Consulting announces the launch of Clarkston's Life Sciences Accelerator, a solution that enables the rapid and efficient deployment of the industry-leading SAP S/4HANA platform.
-
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
11/21/2019
Molecular Templates, Inc. announced the pricing of its underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $8.00 per share and 250 shares of its newly designated Series A convertible preferred stock at a public offering price of $8,000 per share.
-
New target for Parkinson's disease therapy? Blockade of specific calcium channels can protect nerve cells
11/21/2019
Progressive degeneration of dopamine-producing nerve cells in the brain leads to dopamine deficiency and ultimately to Parkinson’s disease.
-
BD Launches Enhanced Antimicrobial Stewardship Analytics Capabilities
11/21/2019
New antimicrobial stewardship technology will be demonstrated at ASHP 2019 Midyear Meeting
-
Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
11/21/2019
Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that Japan’s Ministry of Health, Labour and Welfare has approved the BRACAnalysis® Diagnostic System to help physicians determine which women with breast cancer have Hereditary Breast and Ovarian Cancer syndrome and qualify for additional medical management.
-
FLAMMA CEO given Chinese Citizenship for business efforts in China
11/21/2019
Flamma SpA is proud to announce that Mr. Gian Paolo Negrisoli, Flamma CEO, has been granted Honorary Dalian Citizenship for his friendship to China and his contribution in promoting economic exchanges and cooperation through Flamma Honkai.
-
Entera Bio Reports Third Quarter 2019 Financial Results and Provides Operating Update
11/21/2019
Enrollment Continues for Phase 2 study for oral PTH in Osteoporosis; Top-line 3-month Biomarker Data expected in mid 2020
-
Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
11/21/2019
Immuron completes first meeting with FDA on development of IMM-124E as product to specifically prevent Travelers’ Diarrhea (TD)
-
Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies
11/21/2019
Company Launches with $19 Million in Funding and Rights to IV Meloxicam, Along with Other Clinical-Stage Pipeline Assets
-
Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer
11/21/2019
Entera Bio Ltd. announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan Lieber as its U.S.-based CFO. Mr. Lieber will be responsible for all investor relations, finance and administrative functions, and will lead the Company’s future financing efforts to support the company’s growth initiatives..
-
Record attendance of 4,400 life sciences executives at BIO-Europe® 2019 25th annual celebration in Hamburg
11/21/2019
The highly anticipated 25th annual BIO-Europe® international life sciences partnering conference wrapped up in Hamburg, Germany, last week with an all-time high 4,400 attendees from 2,300 companies and 61 countries, engaging in 27,375 one-to-one partnering meetings, a five percent increase over 2018.